← Eichor
Study identifier: NCT06636578 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block

Condition: Analgesia  ·  Sponsor: Fayoum University

PhasePhase 4
Planned participants90
Who can joinAll sexes, 20 Years to 65 Years
Healthy volunteersYes

About this study

In 2012 Blanco et al. \[1\] described the ultrasound technique for Pectoral nerve (PECS) block as a new, less invasive regional analgesic technique for breast surgeries. PECS block includes PECS I and PECS II (modified PECS I) interfascial blocks. Since that time, PECS block has been used successfully with good results for a wide variety of surgeries on the chest wall such as radical mastectomies, breast-conserving surgeries, breast implant placement, automated implantable cardioverter-defibrillator (AICD)/pacemaker placement, intercostal drainage tube placement, and rib fractures. In this study, the investigators hypothesized that adding dexmedetomidine as an adjuvant to ropivacaine can result in the prolongation of the duration of anesthesia with improvement of the quality of postoperative analgesia of bilateral PECS block for patients undergoing cardiac surgery via midline sternotomy compared with using only plain ropivacaine.

This description comes directly from the study's public registry record.

Talk to the study team

mina fam, M.D  ·  01025273637  ·  mms12@fayoum.edu.eg

Mostafa Elhamamsy, M.D  ·  +966 56 879 9134  ·  mostafah333@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Fayoum University HospitalAl Fayyum, EgyptCompleted
Mohamed HamedAl Fayyum, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06636578